LoginRegister
    Glenmark Pharma to restructure itself into 3 entities in 2019: Chairman Glenn SaldanhaGlenmark Pharma to restructure itself into 3 entities in 2019: Chairman Glenn Saldanha
    AstraZeneca gets Chinese marketing nod for Tagrisso to treat lung cancerAstraZeneca gets Chinese marketing nod for Tagrisso to treat lung cancer
    Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midtermNovartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm
    Lindsay Goldberg to buy Bilcare Research in a deal worth USD 279-334 million: ReportLindsay Goldberg to buy Bilcare Research in a deal worth USD 279-334 million: Report
    Sun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCISun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCI
    Lupin, Boehringer Ingelheim sign USD 700 million deal for novel oncology drugLupin, Boehringer Ingelheim sign USD 700 million deal for novel oncology drug
    Sandoz to commercialize biosimilar of MS drug NatalizumabSandoz to commercialize biosimilar of MS drug Natalizumab
    Former JnJ executive Marianne De Backer to lead Bayer pharma divisionFormer JnJ executive Marianne De Backer to lead Bayer pharma division
    Vertex Pharma, Semma enter deal worth USD 950 million to develop treatments for diabetesVertex Pharma, Semma enter deal worth USD 950 million to develop treatments for diabetes
    Purdue Pharma prepares free-fall bankruptcy as settlement talks halt: ReportPurdue Pharma prepares free-fall bankruptcy as settlement talks halt: Report
    ICMR orders prosecution against Nestle, top Hospitals including Gangaram, Manipal for clinical trial on premature infantsICMR orders prosecution against Nestle, top Hospitals including Gangaram, Manipal for clinical trial...
    Zydus Cadila wins DCGI nod for marketing rabies drug TwinrabZydus Cadila wins DCGI nod for marketing rabies drug Twinrab
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X